Join Us at AACR 2024: Celebrating Progress in Cancer Research

Join Us at AACR 2024: Celebrating Progress in Cancer Research

selective infection

We’re thrilled to announce that we’re returning to the American Association for Cancer Research (AACR) annual meeting for the second time! It’s an honor to be invited back to this prestigious event where we’ll be showcasing our groundbreaking work in the field of cancer therapeutics. AACR is the largest gathering of cancer researchers, clinicians, survivors, and advocates in the world, with over 20,000 attendees. 

Our Progress Since Last Year

Last year’s experience in Orlando was unforgettable. We connected with fellow researchers, explored the latest advancements, and forged valuable partnerships. Reflecting on our debut at AACR, we’ve made significant progress in our research. While our presentation last year highlighted safety data in mice, this year, we’re thrilled to share compelling efficacy data from our latest therapeutic oncolytic virus. Our poster, featuring robust in vitro and in vivo results, promises to spark engaging discussions and inspire collaboration.

Fresh Insights and Connections

We’re eager to share our latest findings and insights with the community. We’re excited to connect with fellow researchers in the field of oncolytic viruses, exchange ideas, and expand our network with pharmaceutical companies. The abstract of our poster has been published by AACR.

Join Us at AACR 2024

We’ll be presenting our poster on Wednesday, April 10th, from 9:00 am to 12:30 pm local time. If you’re attending the meeting, we invite you to stop by our booth and meet our team. We’d love to connect, exchange thoughts, and explore potential collaborations.

Let’s drive progress together in the fight against cancer. See you at AACR 2024!

Leave a Reply

Your email address will not be published.